Clinical trial
The Safety and Tolerability of Intravitreal Infliximab (Remicade) in Patients With Refractory Diabetic Macular Edema or Choroidal Neovascularization Secondary to Age Related Macular Degeneration- A Pilot Study
NCT00695682 is registered in ClinicalTrials.gov with Retina Research Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Safety and Tolerability of Intravitreal Infliximab (Remicade) in Patients With Refractory Diabetic Macular Edema or Choroidal Neovascularization Secondary to Age Related Macular Degeneration- A Pilot Study
- Lead sponsor
- Retina Research Foundation
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- June 30, 2008
- Completion date
- December 31, 2008
- Enrollment
- 4 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.